{"id":13923,"date":"2019-07-27T13:05:09","date_gmt":"2019-07-27T11:05:09","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=13923"},"modified":"2021-07-27T13:19:03","modified_gmt":"2021-07-27T11:19:03","slug":"oyaguez-i-suarez-c-lopez-sendon-jl-gonzalez-juanatey-jr-de-andres-nogales-f-suarez-j-polanco-c-soto-j","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/oyaguez-i-suarez-c-lopez-sendon-jl-gonzalez-juanatey-jr-de-andres-nogales-f-suarez-j-polanco-c-soto-j\/","title":{"rendered":"Oyag\u00fcez I, Su\u00e1rez C, L\u00f3pez-Send\u00f3n JL, Gonz\u00e1lez-Juanatey JR, de Andr\u00e9s-Nogales F, Suarez J, Polanco C, Soto J"},"content":{"rendered":"<div class=\"miniatura_foto\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13915 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/07\/Pharmaco-Open.jpg\" alt=\"\" width=\"90\" height=\"120\" \/><\/div>\n<p style=\"text-align: justify;\"><strong>Oyag\u00fcez I, Su\u00e1rez C, L\u00f3pez-Send\u00f3n JL, Gonz\u00e1lez-Juanatey JR, de Andr\u00e9s-Nogales F, Suarez J, Polanco C, Soto J<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6 style=\"text-align: justify;\">Cost-effectiveness analysis of apixaban versus edoxaban in atrial fibrillation patients for stroke prevention<\/h6>\n<h6 style=\"text-align: justify;\"><strong>Pharmacoecon Open. 2020;4(3):485-497<\/strong><\/h6>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\"><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s41669-019-00186-7?wt_mc=Internal.Event.1.SEM.ArticleAuthorOnlineFirst&amp;utm_source=ArticleAuthorOnlineFirst&amp;utm_medium=email&amp;utm_content=AA_en_06082018&amp;ArticleAuthorOnlineFirst_20191101\" target=\"_blank\" rel=\"noopener\">M\u00c1S INFORMACI\u00d3N<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Oyag\u00fcez I, Su\u00e1rez C, L\u00f3pez-Send\u00f3n JL, Gonz\u00e1lez-Juanatey JR, de Andr\u00e9s-Nogales F, Suarez J, Polanco C, Soto J &nbsp; &nbsp; Cost-effectiveness analysis of apixaban versus edoxaban in atrial fibrillation patients for stroke prevention Pharmacoecon Open. 2020;4(3):485-497 M\u00c1S INFORMACI\u00d3N<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,915,305],"tags":[],"class_list":["post-13923","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-cardiovascular","category-pharmacoeconomics-open","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13923"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13923"}],"version-history":[{"count":3,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13923\/revisions"}],"predecessor-version":[{"id":13926,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13923\/revisions\/13926"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}